Showing results (391-400 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|April 4, 2023
Dendritic cell-based immunotherapy: a potential player in oral cancer therapeuticsRuby Dwivedi, Rahul Pandey, Shaleen Chandra, et al.Immunotherapy|April 6, 2021
Atezolizumab in advanced hepatocellular carcinoma: good things come to those who waitAlessandro Rizzo, Angela Dalia Ricci, Giovanni BrandiImmunotherapy|August 26, 2020
Retreatment with talimogene laherparepvec for advanced melanomaJanice Hu, Sabran J Masoud, Surya Ravichandran, et al.Immunotherapy|April 28, 2021
Safe anti-programmed cell death-1 rechallenge with antibody switching after immune-related adverse events: brief communicationFrancisco Aya, E Azucena González-Navarro, Clara Martínez, et al.Immunotherapy|April 28, 2021
Colitis presenting 5 months after the final dose of anti-PD-1: long-term monitoring is warranted after adjuvant therapyCharlotte Domblides, Marine Gross-Goupil, Alain Ravaud, et al.Immunotherapy|August 20, 2020
Safety and effectiveness of a microcrystalline tyrosine-associated mite extract immunotherapy for allergic rhinitisAnna Sala-Cunill, José L Pérez-Formoso, Carla Torán-Barona, et al.Immunotherapy|April 22, 2021
Long-term immune-related adverse events after discontinuation of immunotherapyKaroline Horisberger, Carmen Portenkirchner, Andreas Rickenbacher, et al.Immunotherapy|April 20, 2021
Cost-effectiveness analysis of ribociclib plus fulvestrant for hormone receptor-positive/human EGF receptor 2-negative breast cancerWei Jiang, Zhichao He, Tiantian Zhang, et al.Immunotherapy|April 21, 2021
Antimicrobial/anticancer peptides: bioactive molecules and therapeutic agentsKimia Kardani, Azam BolhassaniImmunotherapy|October 11, 2012
Solving the dilemma of prevention of red cell alloimmunizationDonald R BranchPageof 188